Highland Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Highland Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,454	Closed	-$266K	–	136
2020 Q2	$266K	Buy	+3,454	New	+$265K	0.06%	106
2018 Q4	–	Sell	-2,841	Closed	-$219K	–	104
2018 Q3	$219K	Buy	+2,841	New	+$215K	0.07%	99
2017 Q4	–	Sell	-2,816	Closed	-$228K	–	98
2017 Q3	$228K	Buy	+2,816	New	+$215K	0.1%	85
2017 Q1	–	Sell	-3,382	Closed	-$243K	–	79
2016 Q4	$243K	Buy	3,382 +192	+6%	+$14.3K	0.12%	65
2016 Q3	$252K	Buy	3,190 +395	+14%	+$32.1K	0.13%	58
2016 Q2	$233K	Sell	2,795 -357	-11%	-$31.7K	0.13%	64
2016 Q1	$289K	Buy	+3,152	New	+$284K	0.17%	46

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Highland Private Wealth Management's GILD Position: Q3 2020 in Review

Highland Private Wealth Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,454 shares — an estimated $266K sold.

Highland Private Wealth Management first reported a position in GILD in Q1 2016 and held it in 7 quarters. The position peaked at $289K in Q1 2016. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Highland Private Wealth Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Highland Private Wealth Management sold 3,454 Gilead Sciences shares in Q3 2020, an estimated $266K.
Highland Private Wealth Management first reported a position in Gilead Sciences in Q1 2016 and held it in 7 quarters.
Highland Private Wealth Management's Gilead Sciences position peaked at $289K in Q1 2016.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Highland Private Wealth Management's 13F filing for Q3 2020, filed 8 Oct 2020.